Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Keryx Biopharmaceuticals Inc. (KERX)

-NCM
15.00 0.15(0.99%) Jul 28, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (46,732) (22,721) (28,123)
Operating Activities, Cash Flows Provided By or Used In
Depreciation54  35  47  
Adjustments To Net Income5,953  (472)1,846  
Changes In Accounts Receivables -  7  (7)
Changes In Liabilities7,291  (1,727)3,820  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(885)115  (406)
Total Cash Flow From Operating Activities (34,319) (24,763) (22,822)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(346)(24)(57)
Investments -  4,212  (4,111)
Other Cash flows from Investing Activities -   -   -  
Total Cash Flows From Investing Activities (346) 4,188   (4,168)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock75,684   -  33,830  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 75,684   -   33,830  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 41,019   (20,575) 6,840  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.